DARE 10-Q: SEC filing

Dare Bioscience

Filed with the SEC on · accession 0001401914-26-000055

DARE filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -11.1% by the first close after the filing.

Summary of the filing

Dare Bioscience filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results including revenue, expenses, and balance sheet data.

Key details

FilerDare Bioscience, Inc.
Collaboration partnerOrganon
Collaboration partnerBayer Healthcare LLC
Acquired entityMicrochips Biotech, Inc.

How DARE stock reacted

Close before

$0.66

Nov 13, 2026

First close after

-11.13%

$0.58

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for DARE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DARE?

Click here

Frequently asked questions

What did DARE file with the SEC on Nov 16, 2026?

DARE filed a 10-Q (SEC filing). Dare Bioscience filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results including revenue, expenses, and balance sheet data.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did DARE stock react to this filing?

DARE closed at $0.66 before the filing and $0.58 on Nov 16, 2026 (-11.13%).

Other DARE SEC filings

Get alerts when DARE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days